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Aim: To investigate the effect of lactic acidosis on the survival of Lewis lung carcinoma cells under glucose-deprived conditions. Materials 
and Methods: LLC/R9 variant of Lewis lung carcinoma cells was cultured in glucose deficit or complete culture medium. Conditions 
of lactic acidosis, lactosis, and acidosis were generated in glucose deficit medium. Cell survival, cell cycle, apoptosis, autophagy, 
and the content of glucose, lactate, vascular endothelial growth factor in the culture medium were determined. Light and fluorescent 
microscopy, flow cytometry, spectrophotometry, and ELISA were used. Results: It has been found that 24 h incubation of tumor cells 
under lactic acidosis caused (i) the reduction of the number of living cells by 33% (p < 0.05) and 56% (p < 0.05); (ii) the inhibition 
of apoptosis by 4.3-fold (p < 0.05) and 3.3-fold (p < 0.05); (iii) the reduction of the rate of glucose consumption by 2-fold (p < 0.05) 
and 2.5-fold (p < 0.05); (iv) an increase of lactate production more than twice (p < 0.05) and 1.6-fold (p < 0.05) compared with these 
indexes under conditions of glucose deficiency or complete glucose-containing medium, respectively. However, on the second day 
of culture under lactic acidosis, the number of viable cells reached a maximum, in contrast to culture in the complete medium. The 
number of live cells on the seventh day of culture under lactic acidosis exceeded almost 2–3 times (p < 0.05) that in the culture under 
conditions of the glucose deprivation or in complete medium. On the third day under lactic acidosis the autophagolysosomes count was 
54% (p < 0.05) lower that that under glucose deficit. Conclusions: Lactic acidosis promoted the survival and proliferation of Lewis lung 
carcinoma cells by energy system reprogramming directed on inhibition of apoptosis and autophagy, a significant decrease in the rate 
of glucose utilization and activation of glutaminolysis and, consequently, increase of the lactate production rate. Inhibition of lactate 
production by tumor cells may be considered as a promising approach for more efficient antiangiogenic treatment of cancer.
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It is known that unlike normal tissue, microenvi-
ronment of malignant cells in a tumor characte rized 
by a shortage of energy and the accumulation of plas-
tic substrates and their metabolic products, gradually 
increasing with the distance from the vessel. This mi-
croenvironment occurs, in part, as a result of disability 
of tumor angiogenesis, and causes the metabolic stress 
in a tumor cell — the dominance of energy consump-
tion vs its production. Tumor cells cannot effectively 
adapt to this metabolic stress because the predominant 
mechanism of adenosine triphosphate (ATP) generation 
in tumor cells is inefficient glycolysis. This offers the 
prospect of inducing the death of cancer cells, creat-
ing or increasing imbalance between the requirement 
of cells in energy and low level of its production (creating 
a “metabolic catastrophe”) [1, 2].
Modern antiangiogenic cancer therapy is aimed 
at inducing a “metabolic catastrophe” in tumor cells 
by inhibiting tumor angiogenesis [3]. The efficiency 
of antiangiogenic therapy depends on the simultane-
ous fulfillment of two conditions: effective inhibition 
of tumor angiogenesis and tumor cell death induced 
by nutrient deprivation, which is caused by a sig-
nificant reduction in tumor vascularity. Meanwhile, 
in many cases, despite the effective inhibition of the 
growth of blood vessels, expected antitumor action 
doesn’t occur [4–7]. The reason for this lack of anti-
tumor effect is the tolerance of tumor cells to meta-
bolic stress. So, understanding the mechanisms that 
ensure the survival of tumor cells under metabolic 
stress is important for improving the efficiency of cur-
rent antiangiogenic cancer therapy and development 
of new anticancer drugs.
The aim of the work was to investigate the effect 
of lactic acidosis on the survival of Lewis lung car-
cinoma cells under conditions of metabolic stress 
induced by glucose deprivation.
MATERIALS AND METHODS
Cell culture. In the work, LLC/R9 variant of Lewis 
lung carcinoma cells was used [8]. Tumor cells are main-
tained in vitro in complete RPMI 1640 medium (Sigma, 
USA) supplemented with 10% fetal calf serum (fetal 
bovine serum (FBS), Sigma, USA) and 40 µg/ml gen-
tamicin at 37 °C in humidified atmosphere of 5% CO2.
To assess the survival of tumor cells under 
lactic acidosis LLC/R9 cells at exponential growth 
phase were seeded in 24-well plates (1.5 • 105 cells/
well) in complete RPMI 1640 medium and incubated 
overnight. Then this medium was replaced with fresh 
media, which differed by the content of glucose, lac-
tate, and pH (Table 1).
Table 1. Glucose and lactate content and pH of the culture medium
Culture conditions Glucose, mМ Lactate, mМ рН
Lactic acidosis 3.0 ± 0.1 14.0 ± 0.7 6.70 ± 0.01
Lactosis 3.0 ± 0.1 14.0 ± 0.7 7.40 ± 0.01
Acidosis 3.0 ± 0.1 1.6 ± 0.7 6.70 ± 0.01
Glucose deficit 3.0 ± 0.1 1.6 ± 0.1 7.40 ± 0.01
Complete medium 9.0 ± 0.5 1.6 ± 0.1 7.40 ± 0.01
For this, we used as a base glucose-free RPMI 
1640 medium (Sigma, USA), which, after adding 10% 
Submitted: May 06, 2017. 
*Correspondence:  E-mail: denkolesnik83@gmail.com 
Abbreviations used: ATP — adenosine triphosphate; FBS — fetal 
bovine serum; MDC — monodansylcadaverine; PBS — phosphate 
buffered saline; VEGF — vascular endothelial growth factor.
Exp Oncol 2017
39, 2, 112–116
Experimental Oncology 39, 112–116, 2017 (June) 113
FBS, was contained glucose and lactate in a final 
concentration of 3.0 mM and 1.6 mM, respectively, 
pH 7.4. Lactic acidosis was generated by adding lactic 
acid (Sigma, USA) to the culture medium to a final con-
centration of 14.0 mM and pH 6.7; lactosis was gene-
rated by adding sodium lactate (Sigma, USA) to a final 
concentration of 14.0 mM and pH 7.4; acidosis was 
generated by adding HCl to a final pH of 6.7. Complete 
culture medium after adding 10% of FBS contained 
9.0 mM glucose, 1.6 mM lactate, pH 7.4. After replac-
ing the medium the cells were additionally incubated 
under standard conditions for 7 days and then following 
indexes were assessed: the number of living cells and 
their cell cycle distribution, apoptosis rate, the level 
of vascular endothelial growth factor (VEGF) produc-
tion, autophagy induction, glucose and lactate content 
in the culture medium.
The number of cells and their viability was evalu-
ated by the routine method by direct counting using 
a 0.4% solution of trypan blue.
Cell cycle distribution was assessed by flow cy-
tometry according to [9]. Briefly, the cells were resus-
pended in hypotonic lysis buffer (0.1% sodium citrate, 
0.1% Triton X-100), which contained 5 mg/ml propi-
dium iodide, and DNA content was analyzed by flow 
cytometry at a wavelength of 488 nm.
The number of apoptotic cells was determined 
by staining with Hoechst 33258 dye (Sigma, USA) us-
ing a fluorescent microscope. To do this, the cells were 
stained with Hoechst 33258 at a final concentration 
of 1 mg/ml at 37 °C for 20 min, washed with saline and 
then the changes in nuclear morphology were evalu-
ated, by counting at least 500 cells/sample. Apoptotic 
cells were determined by the presence or fragmented 
nuclei or condensed chromatin, apoptosis rate was 
expressed as a percentage of total cells.
The VEGF level in cell culture medium was detected 
by ELISA using mouse VEGF kit (Invitrogen, USA) accord-
ing to the manufacturer’s protocol. The rate of VEGF pro-
duction by tumor cells was calculated based on changes 
in VEGF concentration in the culture medium and in the 
number of living cells in the time course.
The level of autophagy in tumor cells was de-
termined using a fluorescent marker monodansylca-
daverine (MDC) (Sigma, USA) [10]. Shortly, the cells 
were incubated with MDC at a final concentration 
of 0.05 mM at 37 °C for 20 min, washed with phosphate 
buffered saline (PBS) and lysed using 10 mM Tris-HCl 
solution with the addition of 1% Triton X-100. Intracellu-
lar MDC levels were determined using fluorometer (ex-
citation filter 360/40 nm, emission filter 528/20 nm). 
Fluorescence intensity was normalized to the number 
of living cells.
Glucose level was measured in the medium 
samples deproteinized with zinc hydroxide by the 
enzymatic glucose-oxidative method using a set for 
determining glucose in biological fluids (Sigma, USA) 
according to the manufacturer’s protocol.
The level of lactate was measured in medium 
samples deproteinized with perchloric acid by the 
enzymatic spectrophotometric method using lactate 
dehydrogenase (Sigma, USA) [11].
In all cases, the studied medium samples were 
collected and stored at –20 °C prior to measurement.
The rate of glucose consumption and lactate pro-
duction in tumor cells was calculated based on the 
concentration of substances in the culture medium and 
changes in the number of living cells in the time course.
Statistical analysis. All measurements were done 
in triplicate and data are presented as mean � s.e. Sta-
tistical analysis was performed by descriptive methods 
and Student’s t-test using Microsoft Excel software 
and Microcal Origin (MicroSoft Inc., USA). p values 
of less than 0.05 were considered as significant.
RESULTS
As it has been found lactic acidosis with glucose de-
privation significantly promoted survival of LLC/R9 cells. 
Despite the slowing proliferation of the studied cells 
on the 1st day of culture under lactic acidosis, already 
on the 2nd day, their proliferation rates increased dra-
matically (Fig. 1). On the 1st day of culture under lactic 
acidosis, the total number of living cells was almost 
by 33% (p < 0.05), 41% (p < 0.05), and 56% (p < 0.05) 
lower than that under conditions of the deficit of glu-
cose, lactose, and complete medium, respectively.
At the same time the maximal number of living cells, 
which was achieved under lactic acidosis on the 2nd day, 
almost 1.5-fold (p < 0.05) exceeded that under condi-
tions of the glucose deprivation, lactosis and acidosis. 
In addition, the maximal number of tumor cells achieved 
under lactic acidosis with glucose depletion did not 
differ significantly from the corresponding value under 
conditions of cell incubation in complete medium.
In the remote terms, the number of cells that sur-
vived on the 7th day of incubation (without replacement 
of the media) under conditions of lactic acidosis and aci-
dosis (in both cases at pH 6.7) was almost by 2–3-fold 
(p < 0.05) higher than that in conditions of glucose de-
privation or complete medium (in both cases, at pH 7.4).
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Fig. 1. Growth kinetics of LLC/R9 cells in vitro under different 
culture conditions
On the 1st day of cell culture, lactic acidosis caused 
the reduction of glucose consumption rate by cells, 
which clearly correlated with a decrease in prolifera-
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tion rate at this time. In the conditions of lactic acidosis 
this index was almost twice lower (p < 0.05) compared 
to that under glucose and lactose deficiency and 
2.5-fold lower (p < 0.05) than that in the complete 
medium (Table 2). Acidosis, as well as lactic acidosis, 
led to a significant reduction of the mentioned index 
to 0.200 � 0.003 µmol/(106 cells•h) (p < 0.05), which 
was associated with the lowest proliferation rate of tu-
mor cells and the presence of glucose in culture medium 
even on the 4th day, unlike all other conditions of incuba-
tion, and the highest cell survival even on the 7th day.
Interestingly, along with the low rate of glucose 
consumption by cells under lactic acidosis their lactate 
production rate was the highest (p < 0.05) compared 
to all other culture conditions (see Table 2). Moreover, 
the ratio between lactate production and glucose con-
sumption significantly exceeded an expected value 
in the case of an effective glycolysis.
Table 2. Glucose consumption and lactate production rates by LLC/
R9 cells under different culture conditions
Culture conditions Glucose consumption rate,μmol/(106 cells•h)
Lactate production rate,
μmol/(106 cells•h)
Glucose deficit 0.328 ± 0.001 0.646 ± 0.003
Acidosis 0.197 ± 0.003 0.278 ± 0.022
Lactosis 0.319 ± 0.003 0.746 ± 0.204
Lactic acidosis 0.164 ± 0.012 1.328 ± 0.048
Complete medium 0.417 ± 0.030 0.807 ± 0.055
Lactic acidosis significantly reduced the percent-
age of apoptotic cells (Fig. 2). So, if at the 1st day 
apoptosis rate was almost the same in all cases, start-
ing from the 2nd day the percentage of apoptotic cells 
under lactic acidosis was 4.3-fold (p < 0.05), 5-fold 
(p < 0.05) and 3.3-fold (p < 0.05) lower compared 
to that under conditions of glucose deprivation, lac-
tosis and complete medium, respectively.
0
5
10
15
20
25
30
1 2 3
Ap
op
to
tic
 c
el
ls
 (%
)
Incubation time (day)
Glucose deficit
*
* *
Acidosis
Lactosis
Lactic acidosis
Complete medium
Fig. 2. Apoptosis level under different culture conditions. 
*p < 0.05 as compared to that in the conditions of glucose deficiency
Significant changes in the cell cycle distribution related 
to the culture conditions were not observed (Table 3). 
Hence, inhibition of cell proliferation, found in the condi-
tions of lactic acidosis on the 1st day and in conditions 
of acidosis during 1–3 days apparently occurred due 
to blocking cell proliferation in all phases of the cell cycle.
There have been no significant effect of lactic aci-
dosis at the background of glucose deficiency on VEGF 
production in LLC/R9 cells (Fig. 3). At least, during the 
1st day, VEGF production rate in cells LLC/R9 in condi-
tions of lactic acidosis did not differ significantly from 
that of all other culture conditions.
Table 3. LLC/R9 cell cycle distribution under different culture conditions
Culture  
conditions Phase
Incubation time, day
1 2 4 7
Lactic aci-
dosis
G0/G1 53.5 ± 1.0 61.6 ± 1.2 60.9 ± 0.5 44.8 ± 0.3
S 36.4 ± 0.1 27.0 ± 1.1 33.7 ± 1.2 48.8 ± 0.6
G2/M 10.1 ± 1.0 11.4 ± 0.1 5.5 ± 0.7 6.5 ± 0.8
Acidosis G0/G1 58.4 ± 0.2 62.3 ± 2.2 55.5 ± 0.8 41.8 ± 0
S 31.1 ± 0.6 25.5 ± 1.5 37.4 ± 0.7 45.2 ± 1.0
G2/M 10.5 ± 0.4 12.2 ± 0.7 7.2 ± 0.1 13.0 ± 1.0
Glucose  
deficit
G0/G1 53.9 ± 0.7 59.8 ± 0.8 58.0 ± 0.7 47.6 ± 0.2
S 35.4 ± 1.0 23.6 ± 0.2 34.2 ± 0.9 45.9 ± 1.2
G2/M 10.7 ± 0.2 16.6 ± 1.0 7.8 ± 0.2 6.5 ± 1.1
Lactosis G0/G1 55.1 ± 1.5 61.5 ± 0.4 65.2 ± 0.6 52.6 ± 1.6
S 34.6 ± 1.8 23.1 ± 0.6 27.1 ± 0.2 39.1 ± 0.7
G2/M 10.3 ± 0.2 15.4 ± 0.1 7.7 ± 0.3 8.4 ± 1.0
Complete 
medium
G0/G1 59.0 ± 0.9 57.8 ± 0.7 66.1 ± 1.3 56.5 ± 3.3
S 30.7 ± 0.3 26.0 ± 0.1 28.8 ± 1.5 36.2 ± 1.7
G2/M 10.3 ± 0.5 16.2 ± 0.8 4.7 ± 0.3 7.3 ± 1.6
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Fig. 3. VEGF production by LLC/R9 cells under different culture 
conditions
Induction of autophagy in tumor cells was tested 
using MDC, which is considered as an autopha-
golysosomal marker due to its ability to accumulate 
in cytoplasmic vacuoles. The data on the number 
of lysosomes in LLC/R9 cells are shown in Fig. 4. 
On the 3rd day of culture, maximal induction of tumor 
cell autophagy under glucose depletion was ob-
served in the conditions of the glucose deficiency 
and lactosis. Instead, autophagy induction under aci-
dosis and lactic acidosis was almost 49% (p < 0.05) 
and 54% (p < 0.05) lower than that in the conditions 
of glucose deprivation.
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Fig. 4. The number of lysosomes in LLC/R9 cells under different 
culture conditions. *p < 0.05 as compared to that in the condi-
tions of deficiency of glucose and lactosis
DISCUSSION
It is known that the microenvironment of tumor cells 
is usually characterized by the deficiency of nutrient 
substrates and accumulation of metabolic products, 
including excessive lactate and consequently low 
extracellular pH [12]. Despite metabolic stress gene-
rated by malignant cells and their high dependence 
on energy and nutrient substrates, they show tolerance 
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to adverse conditions and provide not only survival but 
also highly proliferative and metastatic activity.
One of the mechanisms of malignant cells survival 
in adverse conditions, including nutrient deficiency, is limit-
ing cell proliferation and/or transition into dormancy [13]. 
The mechanisms of survival of tumor cells also include 
a process of autophagy, i.e. lysosomal degradation 
of intracellular components providing malignant cells with 
an alternative source of nutrients and energy substrates 
[13–16]. Growth factors, including VEGF, induce tumor 
angiogenesis that results in the enhancement of supply-
ing tumor with oxygen and nutrients [17]. The resistance 
of tumor cells to metabolic stress can also be associated 
with impaired mechanisms of apoptotic death [18]. Repro-
gramming of energy metabolism, for example, increased 
glucose uptake and activation of glycolysis enzymes 
on the background of hypoxia, is one of the key mecha-
nisms of survival of malignant cells, as they almost always 
exist in unfavorable metabolic microenvironment [19].
In this work lactic acidosis with glucose depriva-
tion significantly promoted cell survival of metastatic 
Lewis lung carcinoma LLC/R9 cells. However, to sur-
vive in such conditions, tumor cells at the initial terms 
of their incubation significantly inhibited the processes 
requiring major energy consumption, such as prolifera-
tion, apoptosis, and autophagy.
Thus, when the cells just began to adapt to the con-
ditions of lactic acidosis the significant slowing of pro-
liferation has been observed. In the same period lactic 
acidosis caused a significant inhibition of apoptosis and 
autophagy, whose level under these conditions in the 
LLC/R9 cells was the lowest among all other culture con-
ditions. Obviously, in terms of further enhancement of nu-
trient substrates deficiency on the background of lactic 
acidosis one could expect induction of autophagy pro-
cesses for cell survival. At least in the later periods of cell 
incubation under conditions of unfed culture, in these 
cells there was observed activation of autophagy [20].
Slowing of the proliferation of LLC/R9 cells, ob-
served in the early stages of incubation under lactic 
acidosis, was accompanied by a significant decrease 
in the rate of glucose utilization by these cells. If in the 
complete culture medium the rate of glucose con-
sumption was the highest, then in the conditions 
of lactic acidosis it was the lowest. This index under 
lactic acidosis was almost twice lower than that in the 
conditions of glucose deprivation and lactosis.
Low consumption of glucose by tumor cells led to the 
fact that glucose was determined in the culture medium 
even on the 3rd day under lactic acidosis, while in the 
conditions of glucose deficiency and lactosis the media 
were completely depleted by glucose at the 2nd day. 
Interestingly, the lowest rate of glucose consumption 
in conditions of lactic acidosis was accompanied with the 
highest rate of lactate production by tumor cells. More-
over, the level of lactate in the culture medium of these 
cells is much higher than this, expected in the case 
of complete metabolism of glucose through glycolysis.
These changes evidenced on a significant adjustment 
in the regulation of energy metabolism of LLC/R9 cells, 
caused by lactic acidosis. These changes can be ex-
plained by activation of oxidative phosphorylation and 
glutaminolysis under conditions of lactic acidosis. The 
latter was confirmed by the high speed of lactate produc-
tion in LLC/R9 cells and the high levels of lactate in the 
culture medium under lactic acidosis. One should note that 
lactosis, unlike lactic acidosis, did not lead to such a pro-
nounced increase in lactate production rate in LLC/R9 cells 
and consecutive activation of glutaminolysis.
As it is known, glutaminolysis is a major (after gly-
colysis) way to provide rapidly tumor cells with energy. 
Activation of glutaminolysis in tumor cells by extracellu-
lar lactate was shown in the work [21], in which signaling 
cascades that are activated with lactate were thoroughly 
investigated. It was found that in oxygenated malignant 
human SiHa and HeLa cells lactate enters the cell 
through monocarboxylate transporter 1 (MCT1), which 
stabilizes HIF-2α, which transactivates c-Myc, which 
in turn enhances the absorption of glutamine by cells 
and activates oxidative phosphorylation.
The important role of lactate in the survival of tumor 
cells is also confirmed by its ability to induce tumor 
angiogenesis through the activation of HIF-1α [22] 
as well as the ability of malignant cells and normal cells 
co-opted in the tumor process, to use it as an energy 
substrate [23, 24]. We also know that lactate can cause 
degradation of the extracellular matrix, increase tumor 
cell migration activity, which is known to correlate with 
their metastatic potential [25, 26].
Therefore, the main adaptive reactions aimed at the 
conservation of mentioned ATP-consuming processes 
in LLC/R9 cells and related to their subsequent survival 
under lactic acidosis occurred only during the 1st day 
of culture. These reactions included dramatic inhibition 
of proliferation, apoptosis, and autophagy, decreased 
glucose consumption rate and activation of glutami-
nolysis. Starting from the 2nd day the active proliferation 
of these cells resumed: the maximal number of live cells 
under lactic acidosis was as high as that in complete 
medium. The levels of dead and apoptotic cells under 
lactic acidosis were the lowest not only in terms of the 
initial incubation, but also for the whole culture duration.
Interestingly, acidosis, as well as lactic acidosis con-
tributed to increased survival of LLC/R9 cells. Obviously, 
under acidosis, these cells used similar mechanisms 
for their survival. However, slowing of the proliferation 
of these cells under acidosis was much more pro-
nounced than that in conditions of lactic acidosis, and 
continued for up to 3 days of culture. In addition, lactate 
production in LLC/R9 cells under acidosis was signifi-
cantly lower than that in the conditions of lactic acidosis. 
However, exactly acidosis provided the maximal survival 
of LLC/R9 cells on the 7th day in all the studied culture 
conditions. Thus, the increased survival of tumor cells 
under acidosis was associated with a slowing of prolife-
ration and inhibition of glycolysis.
The ability of acidosis to promote survival 
of LLC/R9 cells was also confirmed by the data 
on their survival in extreme conditions of incubation, 
namely in PBS supplemented with 10% FBS. As shown 
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in Table 4, survival of LLC/R9 cells after 3-day incuba-
tion in PBS, pH 6.7 was twice higher (p < 0.05), than 
that in the conditions of incubation in PBS, pH 7.4.
Table 4. Survival of LLC/R9 cells under incubation in PBS  
with different рН
Culture condition Viable cell count (10
6 cells)
0 day 3rd day
Control
(PBS + 10% FBS, рН 7.4) 0.15 ± 0.02 0.0319 ± 0.003
Acidosis
(PBS + 10% FBS, рН 6.7) 0.15 ± 0.02 0.0763 ± 0.009*
Note: *p < 0.05 as compared to control.
The role of acidification of the microenvironment 
of tumor cells, but rather an important contribution 
to the excess of hydrogen ions in the extracellular 
environment to their survival is discussed in several 
studies [27–29]. This feature of the tumor microenviron-
ment could be related, in particular, to a predominance 
of cells with glycolytic phenotype and is actively con-
sidered as a promising target for anticancer therapy.
Thus, our findings suggested that acidosis pro-
moted survival of tumor cells, but unlike lactic acidosis 
provided lower proliferative potential. Lactic acidosis not 
only contributed to the survival of tumor cells but also 
allow malignant cells actively proliferate under glucose 
deprivation. Activation of proliferation of LLC/R9 cell was 
preceded by a short period of adaptation to metabolic 
stress, which includes reprogramming of its energy 
system, aimed at energy conservation by inhibiting 
apoptosis and autophagy, a significant decrease in the 
rate of glucose utilization and activation of glutaminoly-
sis and as a result, increased lactate production rate. 
Inhibition of lactate production by tumor cells may 
be viewed as a promising approach for improving the 
efficiency of antiangiogenic cancer therapy.
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